To improve the predictive power of MAD2L2 in prognosis, we constructed a nomogram based on five factors: MAD2L2 expression, IDH mutation status, 1p19q codeletion status, tumor grades, and age (Fig. 2C). This evidence concerns the gene MAD2L2 and neoplasm.